@article{ad4d7e8bdb86418e94475baa1e677880,
title = "An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial",
keywords = "COST-EFFECTIVENESS ANALYSIS, MODIFYING ANTIRHEUMATIC DRUGS, EULAR RECOMMENDATIONS, BIOLOGIC AGENTS, DISCONTINUATION, THERAPY, MANAGEMENT, BOOTSTRAP, UPDATE",
author = "An Tran-Duy and {Ghiti Moghadam}, Marjan and Voshaar, {Martijn A. H. Oude} and Vonkeman, {Harald E.} and Annelies Boonen and Philip Clarke and Geoff McColl and {ten Klooster}, {Peter M.} and Zijlstra, {T. R.} and Lems, {Willem F.} and N. Riyazi and Griep, {E. N.} and Hazes, {J. M. W.} and Robert Landewe and {Bernelot Moens}, {Hein J.} and {van Riel}, {Piet L. C. M.} and {van de Laar}, {Mart A. F. J.} and Jansen, {T. L.} and {Dutch Natl POET Collaboration}",
year = "2018",
month = oct,
day = "1",
doi = "10.1002/art.40546",
language = "English",
volume = "70",
pages = "1557--1564",
journal = "Arthritis & Rheumatology",
issn = "2326-5191",
publisher = "Wiley",
number = "10",
}